Nike and Adidas will reduce their order volumes by 30 percent to 40 percent beginning next summer due to pandemic-related hurdles in China and the pullout of Russia.
Both companies have reportedly notified their manufacturing plants.
The volume decrease is expected to last until the winter, resulting in less footwear on the market until the summer of 2024.
Russia and Ukraine accounted for less than 1 percent of Nike’s total revenue. Nike exited the Russian market in June.
Adidas made up about 2 percent of its revenue in Russia, where it suspended Russia operations in March. The country.
The footwear giants also expect sales to drop in North America and Europe.
Meanwhile, average factory operation rates in Vietnam and Indonesia have already been reduced from between 82 percent and 84 percent to 61 percent.
Over 60 percent of Americans complain that the sluggish economy is impacting their holiday spending.


Can your cat recognise you by scent? New study shows it’s likely
Youth are charting new freshwater futures by learning from the water on the water
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
How did sport become so popular? The ancient history of a modern obsession
Trump Booed at Club World Cup Final, Praises Pele as Soccer’s GOAT
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
Debate over H-1B visas shines spotlight on US tech worker shortages
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Los Angeles Mayor Says White House Must Reassure Fans Ahead of FIFA World Cup
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Australia’s major sports codes are considered not-for-profits – is it time for them to pay up?
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



